James Van Der Beek Teams Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+

Why this matters: Early detection is crucial for successful CRC treatment. New, convenient screening options like the Shield blood test can help increase screening rates and save lives.

Colorectal cancer (CRC) is a significant health concern in the United States. Over 50,000 Americans die from the disease each year, making it the second most deadly cancer in the U.S. However, when detected early, the five-year survival rate is over 90%. Unfortunately, more than 50 million adults aged 45 and over avoid screening, partly due to the unpleasantness and inconvenience of traditional methods.

Guardant Health’s Shield blood test offers a convenient alternative. Approved by the FDA, Shield allows individuals to undergo screening with a simple blood draw, with results available within two weeks. The National Comprehensive Cancer Network has included the Shield blood test in its updated CRC screening guidelines, potentially improving patient access.

James Van Der Beek’s personal experience with CRC has motivated him to advocate for screening. He emphasizes the importance of staying up to date with CRC screening guidelines and encourages others to discuss screening options with their doctors.

The partnership between Van Der Beek and Guardant Health aims to increase awareness and promote the Shield blood test as a convenient and effective screening option. By addressing the barriers to traditional screening methods, this initiative hopes to improve early detection rates and ultimately save lives.

The Shield blood test is a convenient, FDA-approved blood test for colorectal cancer screening for adults 45 and older.

Early detection significantly increases the chances of successful treatment and survival. The five-year survival rate is over 90% when CRC is caught in its early stages.

James Van Der Beek is an actor and health advocate known for his roles in *Varsity Blues* and *Rules of Attraction*. He is partnering with Guardant Health to raise awareness about colorectal cancer screening after being diagnosed with stage 3 CRC.

For more information, visit [www.ShieldCancerScreen.com?ref=yanuki.com](www.ShieldCancerScreen.com?ref=yanuki.com).

Do you think convenient screening options like the Shield blood test will increase early detection rates for colorectal cancer? Share your thoughts in the comments below!

Share this article with others who need to stay ahead of this trend!